Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Cutaneous

Explore clinical trials studying Lupus Erythematosus, Cutaneous. Study availability and eligibility vary by location and protocol.

48 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Cutaneous trial results

Completed

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

NCT02847598

Conditions
Active Cutaneous Lupus Erythematosus, Autoimmune Diseases, Connective Tissue Diseases, +6 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • Arizona Arthritis & Rheumatology Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • TriWest Research Associates, LLC El Cajon, California, United States
View all 128 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

NCT02927457

Conditions
Connective Tissue Diseases, Lupus Erythematosus, Cutaneous, Skin Diseases, +1 more
Locations
  • GSK Investigational Site Tübingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bonn, North Rhine-Westphalia, Germany
  • GSK Investigational Site Münster, North Rhine-Westphalia, Germany
  • GSK Investigational Site Wuppertal, North Rhine-Westphalia, Germany
View Trial Details
Completed

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

NCT01300208

Conditions
Connective Tissue Diseases, Cutaneous Lupus Erythematosus, Lupus Erythematosus, Cutaneous, +3 more
Locations
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Medderm Associates San Diego, California, United States
  • Emory Univ. School of Medicine Atlanta, Georgia, United States
View all 19 locations
View Trial Details
Completed

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

NCT03134222

Conditions
Connective Tissue Diseases, Cutaneous Lupus Erythematosus, Lupus Erythematosus, Cutaneous, +2 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • St. Jude Hospital Yorba Linda DBA Dr. Joseph Heritage Healthcare Fullerton, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Desert Medical Advances Palm Desert, California, United States
View all 16 locations
View Trial Details
Completed

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

NCT01294774

Conditions
Connective Tissue Diseases, Lupus Erythematosus, Cutaneous, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Bochum, Germany
  • Novartis Investigative Site Bonn, Germany
  • Novartis Investigative Site Frankfurt am Main, Germany
  • Novartis Investigative Site Tübingen, Germany
View Trial Details

Related conditions